Table 2.

The incidence of the uropathogens in diabetic patients

Pathogens	Men, n/N (%)	Women, n/N (%)	Patients, n/N (%)
Escherichia coli	8/130 (6.1)	79/130 (60.7)	87/130 (66.9)
Enterobacter spp.	2/130 (1.5)	15/130 (11.5)	17/130 (13)
Streptococcus spp.viridans group	1/130 (0.7)	5/130 (3.8)	6/130 (4.6)
Haemolytic streptococcus	0/130 (0)	1/130 (0.7)	1/130 (0.7)
Staphylococcus epidermidis	0/130 (0)	4/130 (3)	4/130 (3)
Staphylococcus saprophyticus	1/130 (0.7)	3/130 (2.3)	4/130 (3)
Citrobacter spp.	0/130 (0)	2/130 (1.5)	2/130 (1.5)
Acinetobacter spp.	1/130 (0.7)	1/130 (0.7)	2/130 (1.5)
Enterococcus spp.	1/130 (0.7)	2/130 (1.5)	3/130 (2.3)
Klebsiella spp.	0/130 (0)	2/130 (1.5)	2/130 (1.5)
Proteus spp.	0/130 (0)	1/130 (0.7)	1/130 (0.7)
Pseudomonas spp.	0/130 (0)	1/130 (0.7)	1/130 (0.7)
Total	14/130 (10.7)	116/130 (89.2)	130/130 (100)